Canada markets closed

Applied Therapeutics, Inc. (APLT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.30-0.44 (-7.67%)
At close: 04:00PM EST
5.41 +0.11 (+2.08%)
After hours: 08:00PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 443.30M
Enterprise Value 407.15M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)37.21
Price/Book (mrq)4.89
Enterprise Value/Revenue 38.19
Enterprise Value/EBITDA -6.56

Trading Information

Stock Price History

Beta (5Y Monthly) 1.53
52-Week Change 3468.32%
S&P500 52-Week Change 328.18%
52 Week High 36.20
52 Week Low 30.76
50-Day Moving Average 33.16
200-Day Moving Average 32.16

Share Statistics

Avg Vol (3 month) 32.04M
Avg Vol (10 day) 34.29M
Shares Outstanding 577.23M
Implied Shares Outstanding 677.23M
Float 842.94M
% Held by Insiders 17.87%
% Held by Institutions 189.81%
Shares Short (Jan 31, 2024) 43.71M
Short Ratio (Jan 31, 2024) 41.8
Short % of Float (Jan 31, 2024) 45.73%
Short % of Shares Outstanding (Jan 31, 2024) 44.81%
Shares Short (prior month Dec 29, 2023) 41.98M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-586.29%

Management Effectiveness

Return on Assets (ttm)-76.69%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)10.66M
Revenue Per Share (ttm)0.15
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -62.5M
Net Income Avi to Common (ttm)-96.51M
Diluted EPS (ttm)-1.25
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)37.46M
Total Cash Per Share (mrq)0.49
Total Debt (mrq)1.31M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.80
Book Value Per Share (mrq)-0.14

Cash Flow Statement

Operating Cash Flow (ttm)-54.06M
Levered Free Cash Flow (ttm)-20.46M